FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
We received an updated WNV package insert; please note the manufacturer and license number has been ...